Thomas James D 4

What Happened Thomas James, Chief Financial Officer of Nu Skin Enterprises (NUS), was credited with two awards of restricted stock units (RSUs) that became eligible to vest on February 10, 2026. The filing shows acquisitions of 9,847 RSUs and 47,436 RSUs (total 57,283 RSUs) at an acquisition price of $0.00. These were recorded as awards/grants (transaction code A) rather than open-market purchases or sales.

Key Details

• Transaction date(s): February 10, 2026 (eligibility for vesting recognized).
• Grant details: 9,847 RSUs (from grant dated Feb 27, 2024) and 47,436 RSUs (from grant dated Feb 26, 2025).
• Acquisition price reported: $0.00 (typical for awards becoming eligible to vest); total reported cash value in the filing = $0.
• Shares owned after transaction: not disclosed in this Form 4.
• Filing date: February 12, 2026 (filed two days after the report date), which appears timely under normal SEC Form 4 rules.
• Footnotes: F1 and F2 state the RSUs were originally granted on Feb 27, 2024 and Feb 26, 2025 with vesting contingent on company performance; the performance criteria were met on Feb 10, 2026, making the amounts eligible to vest.

Context These entries reflect awards/vesting eligibility (not an open-market purchase or sale). An acquisition price of $0.00 indicates the RSUs were granted as compensation and became eligible to vest due to performance goals being met. This does not necessarily mean shares were sold or that James realized cash—additional filings (or company disclosures) would show actual vesting, delivery of shares, or any tax-withholding actions.